| Period Ending | 31-Mar-2013 | 31-Dec-2012 | 30-Sep-2012 | 30-Jun-2012 |
|---|
|
Total Revenue
|
8,440,000
|
8,434,000
|
8,062,000
|
8,112,000
| | Cost of Revenue | 1,479,000 | 1,501,000 | 1,375,000 | 1,422,000 | | |
Gross Profit
|
6,961,000
|
6,933,000
|
6,687,000
|
6,690,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 5,401,000 | 5,337,000 | 5,160,000 | 5,130,000 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others | 424,000 | 425,000 | 417,000 | 420,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
1,136,000
|
1,171,000
|
1,110,000
|
1,140,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (33,000) | (164,000) | 7,000 | (2,000) |
|
Earnings Before Interest And Taxes | 1,111,000 | 1,017,000 | 1,123,000 | 1,147,000 |
|
Interest Expense | 472,000 | 462,000 | 446,000 | 448,000 |
|
Income Before Tax | 639,000 | 555,000 | 677,000 | 699,000 |
|
Income Tax Expense | 201,000 | 128,000 | 222,000 | 214,000 |
|
Minority Interest | (94,000) | (113,000) | (95,000) | (94,000) |
|
|
|
Net Income From Continuing Ops | 335,000 | 324,000 | 366,000 | 400,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
344,000
|
314,000
|
360,000
|
391,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
344,000
|
314,000
|
360,000
|
391,000
|
|
0.39(1.04%) 9:19PM - Nasdaq Real Time Price